Transaction · 0001193125-26-389564

Sun Nelson

Sun Nelson, SR, reported an open-market or private sale at Aardvark Therapeutics, Inc. involving 62000.000000 shares for an estimated $321178.60. Reported holdings after the transaction were 35475.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SSR
AARDAardvark Therapeutics, Inc.
Trade date
Sep 11, 2026
Filing date
Sep 12, 2026
View on SEC Insider profile
Disclosed value-$321kShares × reported price
Shares traded62.0k$5.18 per share
Holdings after35.4kDirect
% of reported position traded63.61%This security and ownership context
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 97,475 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

AARD price since this filing

Daily closing prices, with the filing date and available return windows
AARD · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago -4.5%1w ago +0.0%1d ago +0.0%
Returns since7d30d90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001193125-26-389564
Common Stock, par value $0.00001 per share
Transaction date
Sep 11, 2026
Filed Sep 12, 2026, 12:14 AM · 1d delay
Shares
62,000 sh
$5.18 per share
Estimated value
-$321k
Computed from shares × price
Holdings after
35,475 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Direct Ownership Large Holdings Reduction Repeat Seller 10b5-1 Detected
Filing-only score

0 points

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • timely_filing+4 points

    reporting_delay_days = 1

    Filing reported within two business days of the transaction.
  • tenb5_1_detected-10 points

    is_10b5_1 = true

    Stored filing content includes detected 10b5-1 language.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

See Remarks

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2026.

  2. F2

    The price reported in Column 4 reflects the weighted-average sales price. These shares were sold in multiple transactions at prices ranging from $5.00 to $5.0007, inclusive. The Reporting Person under…

  3. F3

    Includes 3,745 shares of common stock acquired pursuant to the Issuer's 2025 Employee Stock Purchase Plan on May 22, 2026.

Original filing · 0001193125-26-389564
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

AARD